Aqix Ltd owns a family of EU and US granted patents, (PCT number WO0152647) for the Medical Device formulation, namely;
- Physiological Medium for the Perfusing, Preserving and Storing Isolated Cell, Tissue and Organ Samples. 2000.
and has filed patents (PCT # WO2009004331/2008) for additional uses as a 'therapeutic' in replacing lost body fluids, stem cell transportation and drug delivery applications, namely;
- BODY FLUID EXPANDERS COMPRISING N-SUBSTITUTED AMINOSULFONIC ACID BUFFERS
which have been granted in South Africa (2010;SA2010/00728), EU (2013; EP2175718), Japan (2014;JP5624462), China (2014;CP 200880105723.0) and under divisional examination in the USA which will give the AQIX technology and products protection up to 2028 and beyond.